ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transdermal Drug Delivery Patches Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-21W7601
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Transdermal Drug Delivery Patches Market Insights Forecast to 2028
BUY CHAPTERS

Global Transdermal Drug Delivery Patches Market Research Report 2025

Code: QYRE-Auto-21W7601
Report
July 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan NV
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer Inc
Chattem
Dr. Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Transdermal Drug Delivery Patches Market Size

The global market for Transdermal Drug Delivery Patches was valued at US$ 6943 million in the year 2024 and is projected to reach a revised size of US$ 7906 million by 2031, growing at a CAGR of 1.9% during the forecast period.

Transdermal Drug Delivery Patches Market

Transdermal Drug Delivery Patches Market

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery Patches.
The Transdermal Drug Delivery Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Delivery Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Transdermal Drug Delivery Patches Market Report

Report Metric Details
Report Name Transdermal Drug Delivery Patches Market
Accounted market size in year US$ 6943 million
Forecasted market size in 2031 US$ 7906 million
CAGR 1.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Rx Channel
  • OTC Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Transdermal Drug Delivery Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Transdermal Drug Delivery Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Transdermal Drug Delivery Patches Market growing?

Ans: The Transdermal Drug Delivery Patches Market witnessing a CAGR of 1.9% during the forecast period 2025-2031.

What is the Transdermal Drug Delivery Patches Market size in 2031?

Ans: The Transdermal Drug Delivery Patches Market size in 2031 will be US$ 7906 million.

Who are the main players in the Transdermal Drug Delivery Patches Market report?

Ans: The main players in the Transdermal Drug Delivery Patches Market are Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical

What are the Application segmentation covered in the Transdermal Drug Delivery Patches Market report?

Ans: The Applications covered in the Transdermal Drug Delivery Patches Market report are Rx Channel, OTC Channel

What are the Type segmentation covered in the Transdermal Drug Delivery Patches Market report?

Ans: The Types covered in the Transdermal Drug Delivery Patches Market report are Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Transdermal Patch, Others

Recommended Reports

Transdermal Drug Delivery

Medicated & Specialized Patches

Topical & Pain Relief

1 Transdermal Drug Delivery Patches Market Overview
1.1 Product Definition
1.2 Transdermal Drug Delivery Patches by Type
1.2.1 Global Transdermal Drug Delivery Patches Market Value Comparison by Type (2024 VS 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Drug Delivery Patches by Application
1.3.1 Global Transdermal Drug Delivery Patches Market Value by Application (2024 VS 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Drug Delivery Patches Market Size Estimates and Forecasts
1.4.1 Global Transdermal Drug Delivery Patches Revenue 2020-2031
1.4.2 Global Transdermal Drug Delivery Patches Sales 2020-2031
1.4.3 Global Transdermal Drug Delivery Patches Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transdermal Drug Delivery Patches Market Competition by Manufacturers
2.1 Global Transdermal Drug Delivery Patches Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transdermal Drug Delivery Patches Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transdermal Drug Delivery Patches Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transdermal Drug Delivery Patches, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Drug Delivery Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Drug Delivery Patches, Product Type & Application
2.7 Global Key Manufacturers of Transdermal Drug Delivery Patches, Date of Enter into This Industry
2.8 Global Transdermal Drug Delivery Patches Market Competitive Situation and Trends
2.8.1 Global Transdermal Drug Delivery Patches Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transdermal Drug Delivery Patches Players Market Share by Revenue
2.8.3 Global Transdermal Drug Delivery Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transdermal Drug Delivery Patches Market Scenario by Region
3.1 Global Transdermal Drug Delivery Patches Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transdermal Drug Delivery Patches Sales by Region: 2020-2031
3.2.1 Global Transdermal Drug Delivery Patches Sales by Region: 2020-2025
3.2.2 Global Transdermal Drug Delivery Patches Sales by Region: 2026-2031
3.3 Global Transdermal Drug Delivery Patches Revenue by Region: 2020-2031
3.3.1 Global Transdermal Drug Delivery Patches Revenue by Region: 2020-2025
3.3.2 Global Transdermal Drug Delivery Patches Revenue by Region: 2026-2031
3.4 North America Transdermal Drug Delivery Patches Market Facts & Figures by Country
3.4.1 North America Transdermal Drug Delivery Patches Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transdermal Drug Delivery Patches Sales by Country (2020-2031)
3.4.3 North America Transdermal Drug Delivery Patches Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Drug Delivery Patches Market Facts & Figures by Country
3.5.1 Europe Transdermal Drug Delivery Patches Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transdermal Drug Delivery Patches Sales by Country (2020-2031)
3.5.3 Europe Transdermal Drug Delivery Patches Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Drug Delivery Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Transdermal Drug Delivery Patches Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transdermal Drug Delivery Patches Sales by Region (2020-2031)
3.6.3 Asia Pacific Transdermal Drug Delivery Patches Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transdermal Drug Delivery Patches Market Facts & Figures by Country
3.7.1 Latin America Transdermal Drug Delivery Patches Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transdermal Drug Delivery Patches Sales by Country (2020-2031)
3.7.3 Latin America Transdermal Drug Delivery Patches Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Drug Delivery Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Drug Delivery Patches Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transdermal Drug Delivery Patches Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transdermal Drug Delivery Patches Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Drug Delivery Patches Sales by Type (2020-2031)
4.1.1 Global Transdermal Drug Delivery Patches Sales by Type (2020-2025)
4.1.2 Global Transdermal Drug Delivery Patches Sales by Type (2026-2031)
4.1.3 Global Transdermal Drug Delivery Patches Sales Market Share by Type (2020-2031)
4.2 Global Transdermal Drug Delivery Patches Revenue by Type (2020-2031)
4.2.1 Global Transdermal Drug Delivery Patches Revenue by Type (2020-2025)
4.2.2 Global Transdermal Drug Delivery Patches Revenue by Type (2026-2031)
4.2.3 Global Transdermal Drug Delivery Patches Revenue Market Share by Type (2020-2031)
4.3 Global Transdermal Drug Delivery Patches Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transdermal Drug Delivery Patches Sales by Application (2020-2031)
5.1.1 Global Transdermal Drug Delivery Patches Sales by Application (2020-2025)
5.1.2 Global Transdermal Drug Delivery Patches Sales by Application (2026-2031)
5.1.3 Global Transdermal Drug Delivery Patches Sales Market Share by Application (2020-2031)
5.2 Global Transdermal Drug Delivery Patches Revenue by Application (2020-2031)
5.2.1 Global Transdermal Drug Delivery Patches Revenue by Application (2020-2025)
5.2.2 Global Transdermal Drug Delivery Patches Revenue by Application (2026-2031)
5.2.3 Global Transdermal Drug Delivery Patches Revenue Market Share by Application (2020-2031)
5.3 Global Transdermal Drug Delivery Patches Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Company Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Transdermal Drug Delivery Patches Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Transdermal Drug Delivery Patches Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Company Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB Pharma Transdermal Drug Delivery Patches Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Transdermal Drug Delivery Patches Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Company Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Transdermal Drug Delivery Patches Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.7.1 Nitto Denko Company Information
6.7.2 Nitto Denko Description and Business Overview
6.7.3 Nitto Denko Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nitto Denko Transdermal Drug Delivery Patches Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grünenthal
6.8.1 Grünenthal Company Information
6.8.2 Grünenthal Description and Business Overview
6.8.3 Grünenthal Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Grünenthal Transdermal Drug Delivery Patches Product Portfolio
6.8.5 Grünenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Company Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.9.4 IBSA Group Transdermal Drug Delivery Patches Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Transdermal Drug Delivery Patches Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Company Information
6.11.2 Luye Pharma Group Description and Business Overview
6.11.3 Luye Pharma Group Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Luye Pharma Group Transdermal Drug Delivery Patches Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Company Information
6.12.2 Pfizer Description and Business Overview
6.12.3 Pfizer Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pfizer Transdermal Drug Delivery Patches Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Company Information
6.13.2 Chattem Description and Business Overview
6.13.3 Chattem Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chattem Transdermal Drug Delivery Patches Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Company Information
6.14.2 Dr Reddy’s Laboratories Description and Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Company Information
6.15.2 Bayer Description and Business Overview
6.15.3 Bayer Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bayer Transdermal Drug Delivery Patches Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Company Information
6.16.2 Mundipharma Description and Business Overview
6.16.3 Mundipharma Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mundipharma Transdermal Drug Delivery Patches Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Endo International
6.17.1 Endo International Company Information
6.17.2 Endo International Description and Business Overview
6.17.3 Endo International Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Endo International Transdermal Drug Delivery Patches Product Portfolio
6.17.5 Endo International Recent Developments/Updates
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Company Information
6.18.2 Beijing Tide Pharmaceutical Description and Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Drug Delivery Patches Industry Chain Analysis
7.2 Transdermal Drug Delivery Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Drug Delivery Patches Production Mode & Process Analysis
7.4 Transdermal Drug Delivery Patches Sales and Marketing
7.4.1 Transdermal Drug Delivery Patches Sales Channels
7.4.2 Transdermal Drug Delivery Patches Distributors
7.5 Transdermal Drug Delivery Patches Customer Analysis
8 Transdermal Drug Delivery Patches Market Dynamics
8.1 Transdermal Drug Delivery Patches Industry Trends
8.2 Transdermal Drug Delivery Patches Market Drivers
8.3 Transdermal Drug Delivery Patches Market Challenges
8.4 Transdermal Drug Delivery Patches Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan NV
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer Inc
Chattem
Dr. Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
List of Tables
 Table 1. Global Transdermal Drug Delivery Patches Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Transdermal Drug Delivery Patches Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Transdermal Drug Delivery Patches Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Transdermal Drug Delivery Patches Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Transdermal Drug Delivery Patches Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Transdermal Drug Delivery Patches Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Transdermal Drug Delivery Patches Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Transdermal Drug Delivery Patches Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Transdermal Drug Delivery Patches, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Transdermal Drug Delivery Patches, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Transdermal Drug Delivery Patches, Product Type & Application
 Table 12. Global Key Manufacturers of Transdermal Drug Delivery Patches, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Transdermal Drug Delivery Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Patches as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Transdermal Drug Delivery Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Transdermal Drug Delivery Patches Sales by Region (2020-2025) & (K Units)
 Table 18. Global Transdermal Drug Delivery Patches Sales Market Share by Region (2020-2025)
 Table 19. Global Transdermal Drug Delivery Patches Sales by Region (2026-2031) & (K Units)
 Table 20. Global Transdermal Drug Delivery Patches Sales Market Share by Region (2026-2031)
 Table 21. Global Transdermal Drug Delivery Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Transdermal Drug Delivery Patches Revenue Market Share by Region (2020-2025)
 Table 23. Global Transdermal Drug Delivery Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Transdermal Drug Delivery Patches Revenue Market Share by Region (2026-2031)
 Table 25. North America Transdermal Drug Delivery Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Transdermal Drug Delivery Patches Sales by Country (2020-2025) & (K Units)
 Table 27. North America Transdermal Drug Delivery Patches Sales by Country (2026-2031) & (K Units)
 Table 28. North America Transdermal Drug Delivery Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Transdermal Drug Delivery Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Transdermal Drug Delivery Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Transdermal Drug Delivery Patches Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Transdermal Drug Delivery Patches Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Transdermal Drug Delivery Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Transdermal Drug Delivery Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Transdermal Drug Delivery Patches Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Transdermal Drug Delivery Patches Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Transdermal Drug Delivery Patches Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Transdermal Drug Delivery Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Transdermal Drug Delivery Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Transdermal Drug Delivery Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Transdermal Drug Delivery Patches Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Transdermal Drug Delivery Patches Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Transdermal Drug Delivery Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Transdermal Drug Delivery Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Transdermal Drug Delivery Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Transdermal Drug Delivery Patches Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Transdermal Drug Delivery Patches Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Transdermal Drug Delivery Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Transdermal Drug Delivery Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Transdermal Drug Delivery Patches Sales (K Units) by Type (2020-2025)
 Table 51. Global Transdermal Drug Delivery Patches Sales (K Units) by Type (2026-2031)
 Table 52. Global Transdermal Drug Delivery Patches Sales Market Share by Type (2020-2025)
 Table 53. Global Transdermal Drug Delivery Patches Sales Market Share by Type (2026-2031)
 Table 54. Global Transdermal Drug Delivery Patches Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Transdermal Drug Delivery Patches Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Transdermal Drug Delivery Patches Revenue Market Share by Type (2020-2025)
 Table 57. Global Transdermal Drug Delivery Patches Revenue Market Share by Type (2026-2031)
 Table 58. Global Transdermal Drug Delivery Patches Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Transdermal Drug Delivery Patches Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Transdermal Drug Delivery Patches Sales (K Units) by Application (2020-2025)
 Table 61. Global Transdermal Drug Delivery Patches Sales (K Units) by Application (2026-2031)
 Table 62. Global Transdermal Drug Delivery Patches Sales Market Share by Application (2020-2025)
 Table 63. Global Transdermal Drug Delivery Patches Sales Market Share by Application (2026-2031)
 Table 64. Global Transdermal Drug Delivery Patches Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Transdermal Drug Delivery Patches Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Transdermal Drug Delivery Patches Revenue Market Share by Application (2020-2025)
 Table 67. Global Transdermal Drug Delivery Patches Revenue Market Share by Application (2026-2031)
 Table 68. Global Transdermal Drug Delivery Patches Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Transdermal Drug Delivery Patches Price (US$/Unit) by Application (2026-2031)
 Table 70. Hisamitsu Pharmaceutical Company Information
 Table 71. Hisamitsu Pharmaceutical Description and Business Overview
 Table 72. Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Product
 Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Transdermal Drug Delivery Patches Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis Transdermal Drug Delivery Patches Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. UCB Pharma Company Information
 Table 86. UCB Pharma Description and Business Overview
 Table 87. UCB Pharma Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. UCB Pharma Transdermal Drug Delivery Patches Product
 Table 89. UCB Pharma Recent Developments/Updates
 Table 90. Mylan Company Information
 Table 91. Mylan Description and Business Overview
 Table 92. Mylan Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mylan Transdermal Drug Delivery Patches Product
 Table 94. Mylan Recent Developments/Updates
 Table 95. Teva Pharmaceutical Company Information
 Table 96. Teva Pharmaceutical Description and Business Overview
 Table 97. Teva Pharmaceutical Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Pharmaceutical Transdermal Drug Delivery Patches Product
 Table 99. Teva Pharmaceutical Recent Developments/Updates
 Table 100. Nitto Denko Company Information
 Table 101. Nitto Denko Description and Business Overview
 Table 102. Nitto Denko Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Nitto Denko Transdermal Drug Delivery Patches Product
 Table 104. Nitto Denko Recent Developments/Updates
 Table 105. Grünenthal Company Information
 Table 106. Grünenthal Description and Business Overview
 Table 107. Grünenthal Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Grünenthal Transdermal Drug Delivery Patches Product
 Table 109. Grünenthal Recent Developments/Updates
 Table 110. IBSA Group Company Information
 Table 111. IBSA Group Description and Business Overview
 Table 112. IBSA Group Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. IBSA Group Transdermal Drug Delivery Patches Product
 Table 114. IBSA Group Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. GSK Transdermal Drug Delivery Patches Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Luye Pharma Group Company Information
 Table 121. Luye Pharma Group Description and Business Overview
 Table 122. Luye Pharma Group Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Luye Pharma Group Transdermal Drug Delivery Patches Product
 Table 124. Luye Pharma Group Recent Developments/Updates
 Table 125. Pfizer Company Information
 Table 126. Pfizer Description and Business Overview
 Table 127. Pfizer Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Pfizer Transdermal Drug Delivery Patches Product
 Table 129. Pfizer Recent Developments/Updates
 Table 130. Chattem Company Information
 Table 131. Chattem Description and Business Overview
 Table 132. Chattem Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Chattem Transdermal Drug Delivery Patches Product
 Table 134. Chattem Recent Developments/Updates
 Table 135. Dr Reddy’s Laboratories Company Information
 Table 136. Dr Reddy’s Laboratories Description and Business Overview
 Table 137. Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Product
 Table 139. Dr Reddy’s Laboratories Recent Developments/Updates
 Table 140. Bayer Company Information
 Table 141. Bayer Description and Business Overview
 Table 142. Bayer Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Bayer Transdermal Drug Delivery Patches Product
 Table 144. Bayer Recent Developments/Updates
 Table 145. Mundipharma Company Information
 Table 146. Mundipharma Description and Business Overview
 Table 147. Mundipharma Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Mundipharma Transdermal Drug Delivery Patches Product
 Table 149. Mundipharma Recent Developments/Updates
 Table 150. Endo International Company Information
 Table 151. Endo International Description and Business Overview
 Table 152. Endo International Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Endo International Transdermal Drug Delivery Patches Product
 Table 154. Endo International Recent Developments/Updates
 Table 155. Beijing Tide Pharmaceutical Company Information
 Table 156. Beijing Tide Pharmaceutical Description and Business Overview
 Table 157. Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Product
 Table 159. Beijing Tide Pharmaceutical Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Transdermal Drug Delivery Patches Distributors List
 Table 163. Transdermal Drug Delivery Patches Customers List
 Table 164. Transdermal Drug Delivery Patches Market Trends
 Table 165. Transdermal Drug Delivery Patches Market Drivers
 Table 166. Transdermal Drug Delivery Patches Market Challenges
 Table 167. Transdermal Drug Delivery Patches Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Transdermal Drug Delivery Patches
 Figure 2. Global Transdermal Drug Delivery Patches Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Transdermal Drug Delivery Patches Market Share by Type: 2024 & 2031
 Figure 4. Methyl Salicylate-based Patch Product Picture
 Figure 5. Rivastigmine Transdermal Patch Product Picture
 Figure 6. Fentanyl Transdermal Patch Product Picture
 Figure 7. Lidocaine Patch Product Picture
 Figure 8. Diclofenac Patch Product Picture
 Figure 9. Nicotine Transdermal Patch Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Transdermal Drug Delivery Patches Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Transdermal Drug Delivery Patches Market Share by Application: 2024 & 2031
 Figure 13. Rx Channel
 Figure 14. OTC Channel
 Figure 15. Global Transdermal Drug Delivery Patches Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Transdermal Drug Delivery Patches Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Transdermal Drug Delivery Patches Sales (2020-2031) & (K Units)
 Figure 18. Global Transdermal Drug Delivery Patches Average Price (US$/Unit) & (2020-2031)
 Figure 19. Transdermal Drug Delivery Patches Report Years Considered
 Figure 20. Transdermal Drug Delivery Patches Sales Share by Manufacturers in 2024
 Figure 21. Global Transdermal Drug Delivery Patches Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Transdermal Drug Delivery Patches Players: Market Share by Revenue in Transdermal Drug Delivery Patches in 2024
 Figure 23. Transdermal Drug Delivery Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Transdermal Drug Delivery Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Transdermal Drug Delivery Patches Sales Market Share by Country (2020-2031)
 Figure 26. North America Transdermal Drug Delivery Patches Revenue Market Share by Country (2020-2031)
 Figure 27. United States Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Transdermal Drug Delivery Patches Sales Market Share by Country (2020-2031)
 Figure 30. Europe Transdermal Drug Delivery Patches Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Transdermal Drug Delivery Patches Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Transdermal Drug Delivery Patches Revenue Market Share by Region (2020-2031)
 Figure 38. China Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Transdermal Drug Delivery Patches Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Transdermal Drug Delivery Patches Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Transdermal Drug Delivery Patches Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Transdermal Drug Delivery Patches Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Transdermal Drug Delivery Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Transdermal Drug Delivery Patches by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Transdermal Drug Delivery Patches by Type (2020-2031)
 Figure 59. Global Transdermal Drug Delivery Patches Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Transdermal Drug Delivery Patches by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Transdermal Drug Delivery Patches by Application (2020-2031)
 Figure 62. Global Transdermal Drug Delivery Patches Price (US$/Unit) by Application (2020-2031)
 Figure 63. Transdermal Drug Delivery Patches Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Medicated Adhesive Patch Market Insights Forecast to 2030
Global Pain Relief Patches Market Research Report 2025
Transdermal Patch for Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topical Pain Relief Patch Market Research Report 2024
Transdermal Adhesive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Relieving Patches Market
Non opioid Pain Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transdermal Drug Delivery System Market Insights Forecast to 2030
Global Transdermal Contraceptive Patch Market Research Report 2024
Global Buprenorphine Patches Market Research Report 2024
Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hormones Contraceptive Patch Market Research Report 2024
Global Microneedle Patch Transdermal Drug Delivery Systems Market Research Report 2025
Global Contraceptive Patch Market Research Report 2024
Global Microarray Patch Transdermal Drug Delivery Systems Market Research Report 2025
Non Opioid Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Adhesives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Estradiol Patches Market Research Report 2024
Global Smart Drug releasing Patches Market Research Report 2025
Global Vitamin Transdermal Patch Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions